The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently
Abstract
Prasugrel and clopidogrel inhibit platelet aggregation through active metabolite formation. Prasugrel's active metabolite (R-138727) is formed primarily by cytochrome P450 (CYP) 3A and CYP2B6, with roles for CYP2C9 and CYP2C19. Clopidogrel's activation involves two sequential steps by CYP3A, CYP1A2, CYP2C9, CYP2C19, and/or CYP2B6. In a randomized crossover study, healthy subjects received a loading dose (LD) of prasugrel (60 mg) or clopidogrel (300 mg), followed by five daily maintenance doses (MDs) (15 and 75 mg, respectively) with or without the potent CYP3A inhibitor ketoconazole (400 mg/day). Subjects had a 2-week washout between periods. Ketoconazole decreased R-138727 and clopidogrel active metabolite Cmax (maximum plasma concentration) 34-61% after prasugrel and clopidogrel dosing. Ketoconazole did not affect R-138727 exposure or prasugrel's inhibition of platelet aggregation (IPA). Ketoconazole decreased clopidogrel's active metabolite AUC0-24 (area under the concentration-time curve to 24 h postdose) 22% (LD) to 29% (MD) and reduced IPA 28% (LD) to 33% (MD). We conclude that CYP3A4 and CYP3A5 inhibition by ketoconazole affects formation of clopidogrel's but not prasugrel's active metabolite. The decreased formation of clopidogrel's active metabolite is associated with reduced IPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Hulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Identification and Biological Activity of the Active Metabolite of Clopidogrel
Savi, P., Pereillo, J. M., Uzabiaga, M. F., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M., & Herbert, J. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614133 · Cited by 754
Lau, W. C., Waskell, L. A., Watkins, P. B., Neer, C. J., Horowitz, K., Hopp, A. S., Tait, A. R., Carville, D. G. M., Guyer, K. E., & Bates, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000047060.60595.cc · Cited by 688
Müller, I., Besta, F., Schulz, C., Massberg, S., Schönig, A., & Gawaz, M. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613462 · Cited by 585
Brandt, J. T., Payne, C. D., Wiviott, S. D., Weerakkody, G., Farid, N. A., Small, D. S., Jakubowski, J. A., Naganuma, H., & Winters, K. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.010 · Cited by 571
Self-citationJernberg, T., Payne, C. D., Winters, K. J., Darstein, C., Brandt, J. T., Jakubowski, J. A., Naganuma, H., Siegbahn, A., & Wallentin, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi877 · Cited by 538
Self-citationLau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Clarke, T. A., & Waskell, L. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.53 · Cited by 374
Rehmel, J. L. F., Eckstein, J. A., Farid, N. A., Heim, J. B., Kasper, S. C., Kurihara, A., Wrighton, S. A., & Ring, B. J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007989 · Cited by 261
Self-citationSugidachi, A., Asai, F., Ogawa, T., Inoue, T., & Koike, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703237 · Cited by 234
Ding, Z., Kim, S., Dorsam, R. T., Jin, J., & Kunapuli, S. P. (2003) · Blood · doi:10.1182/blood-2002-10-3027 · Cited by 208
Suh, J.-W. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060664 · Cited by 204
Neubauer, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00442-1 · Cited by 201
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
Müller, I. I., Besta, F., Schulz, C., Li, Z., Maßberg, S., & Gawaz, M. (2003) · Circulation · doi:10.1161/01.cir.0000099507.32936.c0 · Cited by 126
Farid, N. A., McIntosh, M., Garofolo, F., Wong, E. Y. K., Shwajch, A., Kennedy, M. J., Young, M., Sarkar, P., Kawabata, K., Takahashi, M., et al. (2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2813 · Cited by 122
Self-citationCumulative antiplatelet effect of low‐dose enteric coated aspirin
Jakubowski, J. A., Stampfer, M. J., aillancourt, R. V., & Deykin, D. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07467.x · Cited by 99
Self-citationPoulsen, T. S., Vinholt, P. J., Mickley, H., Korsholm, L., Kristensen, S. R., & Damkier, P. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960203.x · Cited by 17
Cited by
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809171 · Cited by 2,497
Self-citationScott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.105 · Cited by 962
Wiviott, S. D., Trenk, D., Frelinger, A. L., O’Donoghue, M., Neumann, F.-J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.740324 · Cited by 881
Self-citationKazui, M., Nishiya, Y., Ishizuka, T., Hagihara, K., Farid, N. A., Okazaki, O., Ikeda, T., & Kurihara, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029132 · Cited by 835
Self-citationBRANDT, J. T., CLOSE, S. L., ITURRIA, S. J., PAYNE, C. D., FARID, N. A., ERNEST, C. S., LACHNO, D. R., SALAZAR, D., & WINTERS, K. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02775.x · Cited by 734
Self-citation
Metadata
- Authors
- Farid, N. A., Payne, C. D., Small, D. S., Winters, K. J., Ernest, C. S., Brandt, J. T., Darstein, C., Jakubowski, J. A., & Salazar, D. E.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-03-14
- Volume
- 81
- Issue
- 5
- Pages
- 735-741
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2140220482
- Cited by
- 323
- References
- 19
- FWCI
- 30.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.